Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion type Assertion NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_head.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion description "[Similarly in those patients who used oral contraceptive with variant CT genotype, there was statistically highly significant reduced risk of cervix cancer (OR:0.25, 95% CI: -0.12-0.49, P<0.001) of methylenetetrahydrofolate reductase gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_provenance.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion evidence source_evidence_literature NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_provenance.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion SIO_000772 18351371 NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_provenance.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion wasDerivedFrom befree-20140225 NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_provenance.
- NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_assertion wasGeneratedBy ECO_0000203 NP264908.RAkTEorF-pOjyx80Y4fZHef6KDYaVFkmctQIcOkZt7CBY130_provenance.